Skip banner
HomeSourcesHow Do I?OverviewHelp
Return To Search FormFOCUS
Search Terms: patent, extension, drug

Document ListExpanded ListKWICFULL format currently displayed

Previous Document Document 137 of 195. Next Document

Copyright 1999 Times Publishing Company  
St. Petersburg Times

November 16, 1999, Tuesday, 0 South Pinellas Edition

SECTION: EDITORIAL; COLUMNS; Correction; Pg. 15A

LENGTH: 731 words

HEADLINE: Bayfront treats retirees despicably

BYLINE: MARTIN DYCKMAN

BODY:
 "Dirty trick," as 82-year-old Edith Campbell put it, seems almost too polite a description of how Bayfront Medical Center has terminated medical benefits for its retirees and their spouses.

The word that comes to my mind is "despicable." 

Pick any word you like, but please call Bayfront at (727) 823-1234 and share it with Sue Brody, the administrator. That will do more good than anything the media might do.

The decision applies not just to current workers, who were put on notice last year but to people already retired. They had spent years, if not their entire working lifetimes, at the hospital in the expectation of a dignified old age. Unlike those still on the job, most can't go looking for another employer who might treat them better. Nor can they go back and put money aside to cushion the blow. Out of a meager $ 1,360 in pension and Social Security, how is a retired nurse such as Campbell suddenly to absorb $ 600 a month in pharmaceutical costs?

Though we've come to expect such corporate callousness in our supposedly "kinder, gentler" America, Bayfront's excuses, as reported by my colleague Kris Hundley, were notably brazen.

You'd expect administrators to say that the hospital, having lost $ 5.2-million last year, could no longer afford over-65 medical benefits.

But no, administrators say it's not the money. Rather, it's because none of the other hospitals in the BayCare health system, which Bayfront joined two years ago, offer retiree health benefits. It would cost too much to extend them to everyone. And of course no law prevents Bayfront from doing what it did.

In other words, the retirees are being sacrificed to ruthless consistency, not necessity. Necessity may compel reducing Bayfront's prospective benefits to the levels of its new partners, but it is neither necessary nor logical to take benefits away from Bayfront retirees who already had earned them. Surely none of the other hospitals' retirees would expect that. Federal law wouldn't let Bayfront repeal pensions, but it regrettably does not vest retirees with similar rights to health care.

Bayfront would be more credible to cry poor. It's easy, though, to see why they might not want to. Among other things, it would invite comparison with the compensation of BayCare head Frank Murphy, who got $ 554,144 in 1997, and the $ 300,000-plus Brody will get this year as chief executive of Bayfront-St. Anthony's.  Retiree health care was costing Bayfront only $ 340,000 a year, which would have been swiftly self-limiting if only those already retired were kept on.

It could reasonably occur to prospective patients to ask what kind of care strangers might expect from a hospital that would treat its own elders in such a way.

Remember the phone number: (727) 823-1234.

If you're a retiree and have to ask what your medicine costs, chances are high you can't afford it. One in four Americans older than 65 pay at least $ 500 a year of their own money for pharmaceuticals and 12 percent pay more than $ 1,000. The price-gouging has left seniors vulnerable to Medicare HMOs that enticed them with prescription benefits that turned sour when costs rose.

But Congress hasn't budged, not even to apply Medicare's potential purchasing clout as President Clinton has proposed.

An instructive side issue is Schering-Plough's massive campaign to win a patent extension past 2002 for its pricey and wildly profitable anti-allergy drug Claritin. The game is to write something into one of the last-minute budget bills to empower (and by inference, require) the Patent Office to grant a three-year extension. Florida Sen. Connie Mack supports the company, as does his would-be successor Rep. Bill McCollum.

Equities aside, Schering-Plough's tactics are legal but obscene. It is spending $ 4-million a year on lobbyists including Senate Minority Leader Tom Daschle's wife and Al Gore confidant Peter Knight. It has contributed $ 923,000 in political party "soft money" since 1992 and has made its corporate aircraft available at less than cost to Senate Majority Leader Trent Lott, a frequent flier, and other pols.

If that's what one drug is worth, imagine what the pharmaceuticals will spend collectively to preserve their status as the nation's most profitable industry.

CORRECTION: Rep. George Albright of Ocala is a Republican. Sunday's column misidentified him.



LOAD-DATE: November 16, 1999




Previous Document Document 137 of 195. Next Document


FOCUS

Search Terms: patent, extension, drug
To narrow your search, please enter a word or phrase:
   
About LEXIS-NEXIS® Academic Universe Terms and Conditions Top of Page
Copyright © 2001, LEXIS-NEXIS®, a division of Reed Elsevier Inc. All Rights Reserved.